Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma

M. Balducci,Alba Fiorentino,P. De Bonis,Silvia Chiesa,Annunziato Mangiola,Gian Carlo Mattiucci,Giuseppe Roberto D’Agostino,V. Frascino,G. Mantini,A.R. Alitto,Cesare Colosimo,Carmelo Anile,Vincenzo Valentini

Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma

2013

M. Balducci
Alba Fiorentino
P. De Bonis
Silvia Chiesa
Annunziato Mangiola
Gian Carlo Mattiucci
Giuseppe Roberto D’Agostino
V. Frascino
G. Mantini
A.R. Alitto
Cesare Colosimo
Carmelo Anile
Vincenzo Valentini

Aim To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).

Keywords:

Pathology
Glioblastoma
Temozolomide
Radiation therapy
Adjuvant
Medicine
Internal medicine
Cancer research
Chemotherapy
Oncology
Chemoradiotherapy
Dacarbazine
Combined Modality Therapy
Concomitant
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations